Infant Formula With a Specific Blend of Five Human Milk Oligosaccharides Drives the Gut Microbiota Development and Improves Gut Maturation Markers: A Randomized Controlled Trial.

Bosheva, Miroslava; Tokodi, Istvan; Krasnow, Aleksander; Pedersen, Helle Krogh; Lukjancenko, Oksana; Eklund, Aron C; Grathwohl, Dominik; Sprenger, Norbert; Berger, Bernard; Cercamondi, Colin I

Bosheva, Miroslava; Tokodi, Istvan; Krasnow, Aleksander; Pedersen, Helle Krogh; Lukjancenko, Oksana; Eklund, Aron C; Grathwohl, Dominik; Sprenger, Norbert; Berger, Bernard; Cercamondi, Colin I.

Afiliação

Bosheva M; University Multiprofile Hospital for Active Treatment, St. George Medical University, Plovdiv, Bulgaria.
Tokodi I; Infant and Children's Department, St. George's Hospital, Székesfehérvár, Hungary.
Krasnow A; Gdansk Health Center, Gdansk, Poland.
Pedersen HK; Clinical Microbiomics, Copenhagen, Denmark.
Lukjancenko O; Clinical Microbiomics, Copenhagen, Denmark.
Eklund AC; Clinical Microbiomics, Copenhagen, Denmark.
Grathwohl D; Biostatistics and Data, Nestlé Research, Lausanne, Switzerland.
Sprenger N; Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Berger B; Nestlé Institute of Health Sciences, Nestlé Research, Lausanne, Switzerland.
Cercamondi CI; Nestlé Product Technology Center - Nutrition, Société des Produits Nestlé S.A., Vevey, Switzerland.

Front Nutr ; 9: 920362, 2022.

Article em En | MEDLINE | ID: mdl-35873420

Palavras-chave

Bifidobacterium longum subsp. infantis (B. infantis); Clostridioides (C.) difficile; bifidobacteria; gut maturation; gut microbiota; human milk oligosaccharides (HMOs); infant formula; intestinal immune response

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Front Nutr Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bulgária

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google